Literature DB >> 4916020

Estrogen treatment for cancer of the prostate. Early results with 3 doses of diethylstilbestrol and placebo.

J C Bailar, D P Byar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4916020     DOI： 10.1002/1097-0142(197008)26:2<257::aid-cncr2820260203>3.0.co;2-9

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  21 in total

1.  Prostatic cancer.

Authors:  E P O'Donoghue; G D Chisholm
Journal:  Br Med J       Date:  1976-11-27

2.  Inhibition of androgen-independent prostate cancer by estrogenic compounds is associated with increased expression of immune-related genes.

Authors:  Ilsa M Coleman; Jeffrey A Kiefer; Lisha G Brown; Tiffany E Pitts; Peter S Nelson; Kristen D Brubaker; Robert L Vessella; Eva Corey
Journal:  Neoplasia       Date:  2006-10       Impact factor: 5.715

3.  Orchidectomy versus oestrogen for prostatic cancer: cardiovascular effects.

Authors:  P Henriksson; O Edhag
Journal:  Br Med J (Clin Res Ed)       Date:  1986-08-16

4.  The current status of adjuvant hormonal therapy combined with radiation therapy for localised prostate cancer.

Authors:  J Armstrong
Journal:  Ir J Med Sci       Date:  1998 Jul-Sep       Impact factor: 1.568

Review 5.  Current concepts in the management of carcinoma of the prostate gland.

Authors:  E M Meares
Journal:  Calif Med       Date:  1972-12

6.  Oral contraceptive use in patients with thromboembolism following surgery, trauma, or infection.

Authors:  G R Greene; P E Sartwell
Journal:  Am J Public Health       Date:  1972-05       Impact factor: 9.308

7.  Treatment of advanced prostatic carcinoma.

Authors: 
Journal:  Br Med J       Date:  1979-09-29

8.  Effects of oestrogen therapy and orchidectomy on coagulation and prostanoid synthesis in patients with prostatic cancer.

Authors:  P Henriksson; M Blombäck; G Bratt; O Edhag; A Eriksson; O Vesterqvist
Journal:  Med Oncol Tumor Pharmacother       Date:  1989

9.  Phase III study of combined chemohormonal therapy in metastatic prostate cancer (ECOG 3882): an Eastern Cooperative Oncology Group study.

Authors:  Andrea N Leaf; Kathleen Propert; Chris Corcoran; Paul J Catalano; Donald L Trump; Jules E Harris; Thomas E Davis
Journal:  Med Oncol       Date:  2003       Impact factor: 3.064

10.  Effects of ethinyl oestradiol/polyoestradiol phosphate and estramustine phosphate on some proteins related to haemostasis in prostatic carcinoma patients.

Authors:  J E Damber; L Daehlin; R Tomic; T K Nilsson
Journal:  Int Urol Nephrol       Date:  1991       Impact factor: 2.370
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.